LB1_11

General Information


DRACP ID  DRACP05383

Peptide Name   LB1_11

Sequence  SXRSXRILFQYSXRSXR

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  N-terminal alkyne is introduced using 4-pentynoic acid

C-terminal Modification  Amidation

Other Modification  X=aminohexyl residue

Chiral  L



Physicochemical Information


Formula  C71H110N26O16

Absent amino acids  ACDEGHKMNPTVW

Common amino acids  RSX

Mass  230935

Pl  12.5

Basic residues  4

Acidic residues  0

Hydrophobic residues  3

Net charge  4

Boman Index  -6614

Hydrophobicity  -87.65

Aliphatic Index  45.88

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  93.13

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24105028

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2114

DRACP is developed by Dr.Zheng's team.